Ann: Consolidation/Split - OSP, page-7

cash in hand for 4 qtrs + income would
make this closer to 5, if covid remains as blocker for elective/non urgent surgeries which require use of DyeVert then id guess 6 months.

though that said part of the GE deal there is option for GE to fund manufacturing costs of the product and osp just gets profit which reduces the need for upfront cost of sales